These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38997314)

  • 1. Retinal hyperspectral imaging in mouse models of Parkinson's disease and healthy aging.
    Trlin P; Gong J; Tran KKN; Wong VHY; Lee PY; Hoang A; Zhao D; Beauchamp LC; Lim JKH; Metha A; Barnham KJ; Finkelstein DI; Bui BV; Bedggood P; Nguyen CTO
    Sci Rep; 2024 Jul; 14(1):16089. PubMed ID: 38997314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated accumulation of retinal α-synuclein (pSer129) and tau, neuroinflammation, and autophagic dysregulation in a seeded mouse model of Parkinson's disease.
    Mammadova N; Summers CM; Kokemuller RD; He Q; Ding S; Baron T; Yu C; Valentine RJ; Sakaguchi DS; Kanthasamy AG; Greenlee JJ; Heather West Greenlee M
    Neurobiol Dis; 2019 Jan; 121():1-16. PubMed ID: 30218757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retina as a Model to Study In Vivo Transmission of α-Synuclein in the A53T Mouse Model of Parkinson's Disease.
    Mammadova N; Baron T; Verchère J; Greenlee JJ; Greenlee MHW
    Methods Mol Biol; 2021; 2224():75-85. PubMed ID: 33606207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct retinal reflectance spectra from retinal hyperspectral imaging in Parkinson's disease.
    Ueda E; Watanabe M; Nakamura D; Matsuse D; Tanaka E; Fujiwara K; Hashimoto S; Nakamura S; Isobe N; Sonoda KH
    J Neurol Sci; 2024 Jun; 461():123061. PubMed ID: 38797139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visualizing alpha-synuclein and iron deposition in M83 mouse model of Parkinson's disease in vivo.
    Straumann N; Combes BF; Dean Ben XL; Sternke-Hoffmann R; Gerez JA; Dias I; Chen Z; Watts B; Rostami I; Shi K; Rominger A; Baumann CR; Luo J; Noain D; Nitsch RM; Okamura N; Razansky D; Ni R
    Brain Pathol; 2024 Nov; 34(6):e13288. PubMed ID: 38982662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal hyperspectral imaging in the 5xFAD mouse model of Alzheimer's disease.
    Lim JKH; Li QX; Ryan T; Bedggood P; Metha A; Vingrys AJ; Bui BV; Nguyen CTO
    Sci Rep; 2021 Mar; 11(1):6387. PubMed ID: 33737550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. l-3,4-dihydroxyphenylalanine (l-DOPA) modulates brain iron, dopaminergic neurodegeneration and motor dysfunction in iron overload and mutant alpha-synuclein mouse models of Parkinson's disease.
    Billings JL; Gordon SL; Rawling T; Doble PA; Bush AI; Adlard PA; Finkelstein DI; Hare DJ
    J Neurochem; 2019 Jul; 150(1):88-106. PubMed ID: 30716176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic DNA levels of mutant alpha-synuclein correlate with non-motor symptoms in an A53T Parkinson's disease mouse model.
    Wang W; Song N; Jia F; Tang T; Bao W; Zuo C; Xie J; Jiang H
    Neurochem Int; 2018 Mar; 114():71-79. PubMed ID: 29355568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal live imaging of retinal α-synuclein::GFP deposits in a transgenic mouse model of Parkinson's Disease/Dementia with Lewy Bodies.
    Price DL; Rockenstein E; Mante M; Adame A; Overk C; Spencer B; Duong-Polk KX; Bonhaus D; Lindsey J; Masliah E
    Sci Rep; 2016 Jul; 6():29523. PubMed ID: 27389831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model.
    Taguchi T; Ikuno M; Hondo M; Parajuli LK; Taguchi K; Ueda J; Sawamura M; Okuda S; Nakanishi E; Hara J; Uemura N; Hatanaka Y; Ayaki T; Matsuzawa S; Tanaka M; El-Agnaf OMA; Koike M; Yanagisawa M; Uemura MT; Yamakado H; Takahashi R
    Brain; 2020 Jan; 143(1):249-265. PubMed ID: 31816026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral inflammation exacerbates α-synuclein toxicity and neuropathology in Parkinson's models.
    La Vitola P; Balducci C; Baroni M; Artioli L; Santamaria G; Castiglioni M; Cerovic M; Colombo L; Caldinelli L; Pollegioni L; Forloni G
    Neuropathol Appl Neurobiol; 2021 Feb; 47(1):43-60. PubMed ID: 32696999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Orexin/Hypocretin Neurons Ameliorates Elevated Physical Activity and Energy Expenditure in the A53T Mouse Model of Parkinson's Disease.
    Stanojlovic M; Pallais JP; Kotz CM
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic deletion of nitric oxide synthase 2 ameliorates Parkinson's disease pathology and neuroinflammation in a transgenic mouse model of synucleinopathy.
    Kim J; Han JY; Lee Y; Kim K; Choi YP; Chae S; Hoe HS
    Mol Brain; 2023 Jan; 16(1):7. PubMed ID: 36647152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A53T-α-synuclein overexpression in murine locus coeruleus induces Parkinson's disease-like pathology in neurons and glia.
    Henrich MT; Geibl FF; Lee B; Chiu WH; Koprich JB; Brotchie JM; Timmermann L; Decher N; Matschke LA; Oertel WH
    Acta Neuropathol Commun; 2018 May; 6(1):39. PubMed ID: 29747690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal Metabolomics Profiling of Parkinson's Disease-Related α-Synuclein A53T Transgenic Mice.
    Chen X; Xie C; Sun L; Ding J; Cai H
    PLoS One; 2015; 10(8):e0136612. PubMed ID: 26317866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caffeic acid reduces A53T α-synuclein by activating JNK/Bcl-2-mediated autophagy in vitro and improves behaviour and protects dopaminergic neurons in a mouse model of Parkinson's disease.
    Zhang Y; Wu Q; Zhang L; Wang Q; Yang Z; Liu J; Feng L
    Pharmacol Res; 2019 Dec; 150():104538. PubMed ID: 31707034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal α-synuclein deposits in Parkinson's disease patients and animal models.
    Veys L; Vandenabeele M; Ortuño-Lizarán I; Baekelandt V; Cuenca N; Moons L; De Groef L
    Acta Neuropathol; 2019 Mar; 137(3):379-395. PubMed ID: 30721408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tauopathic changes in the striatum of A53T α-synuclein mutant mouse model of Parkinson's disease.
    Wills J; Credle J; Haggerty T; Lee JH; Oaks AW; Sidhu A
    PLoS One; 2011 Mar; 6(3):e17953. PubMed ID: 21445308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurodegeneration and contralateral α-synuclein induction after intracerebral α-synuclein injections in the anterior olfactory nucleus of a Parkinson's disease A53T mouse model.
    Flores-Cuadrado A; Saiz-Sanchez D; Mohedano-Moriano A; Martinez-Marcos A; Ubeda-Bañon I
    Acta Neuropathol Commun; 2019 Apr; 7(1):56. PubMed ID: 30987677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visualizing alpha-synuclein and iron deposition in M83 mouse model of Parkinson's disease
    Straumann N; Combes BF; Dean Ben XL; Sternke-Hoffmann R; Gerez JA; Dias I; Chen Z; Watts B; Rostami I; Shi K; Rominger A; Baumann CR; Luo J; Noain D; Nitsch RM; Okamura N; Razansky D; Ni R
    bioRxiv; 2023 Jun; ():. PubMed ID: 37425954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.